Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Response
100%
Thiopurines
100%
Immune Checkpoint Blockade
100%
Tumor Immunogenicity
100%
6-thioguanine (6-TG)
100%
Neoepitope
33%
Tumor Control
33%
DNA-TG
33%
Immune Checkpoint Inhibitors
33%
Immune Response
16%
Tumor
16%
Mouse Model
16%
Tumor Cells
16%
Prodrug
16%
Cell-to-cell
16%
Cell Death
16%
Treatment-resistant
16%
Cancer Patients
16%
T Cells
16%
Melanoma
16%
Melanoma Cells
16%
Immune Cells
16%
T-cell Mediated
16%
Tumor Microenvironment
16%
Single nucleotide
16%
Phase I Trial
16%
Tumor Cell Proliferation
16%
Preclinical Animal Models
16%
Highly Effective
16%
Clinical Grade
16%
Thioguanine nucleotides
16%
Largest Subset
16%
Immune Checkpoint Therapy
16%
Random mutation
16%
Tumor mutational Burden
16%
Drug-resistant Cancer
16%
Immunology and Microbiology
Immune Checkpoint Blockade
100%
Tumor Immunogenicity
100%
Immune Checkpoint Inhibitor
100%
Mouse Model
66%
T Cell
66%
Tumor Cell
66%
Immunocompetent Cell
33%
Immune Response
33%
Cell Proliferation
33%
Cell Death
33%
Melanoma Cell Line
33%
Tumor Mutational Burden
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Tioguanine
100%
Mercaptopurine
100%
Immunogenicity
100%
Malignant Neoplasm
42%
Immune Checkpoint Inhibitor
42%
Mouse Model
28%
Melanoma
28%
Clinical Trial
14%
Prodrug
14%
Tumor Microenvironment
14%
Medicine and Dentistry
Tumor Immunogenicity
100%